Reviva Pharmaceuticals Holdings's total assets for Q4 2025 were $15.92T, an increase of 111097283.32% from the previous quarter. RVPH total liabilities were $7.28T for the fiscal quarter, a 74369898.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.